Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $8.88 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.53.
Market Cap
8.88T
Revenue
4.59T
Profits
199.44B
PE Ratio
44.53
Profit Margin
4.35%
Dividend Yield
0.40%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | -1.05% | 1,555,749 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 615.36B | 2.00% | 9,099,186 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 447.53B | -1.09% | 4,953,150 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 391.69B | -1.16% | 4,233,938 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 314.83B | 0.96% | 7,791,477 | 65.77B |
| 6 | NVS | Novartis AG | 292.88B | -0.51% | 1,458,860 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 263.57B | 0.23% | 1,683,719 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 215.75B | -2.41% | 8,289,356 | 50.57B |
| 9 | AMGN | Amgen Inc. | 197.56B | -0.05% | 1,548,370 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 195.64B | 0.57% | 2,334,423 | 45.20B |
| 11 | ABT | Abbott Laboratories | 175.17B | 0.90% | 10,257,525 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 161.83B | 0.05% | 4,757,037 | 29.74B |
| 13 | PFE | Pfizer Inc. | 141.46B | -0.48% | 32,988,265 | 63.32B |
| 14 | CVS | CVS Health Corporation | 137.90B | -2.28% | 9,536,153 | 405.62B |
| 15 | DHR | Danaher Corporation | 125.93B | 0.07% | 10,886,712 | 25.11B |
| 16 | BMY | Bristol-Myers Squibb Company | 124.08B | -0.28% | 6,796,325 | 48.48B |
| 17 | ISRG | Intuitive Surgical, Inc. | 120.36B | -2.68% | 4,527,385 | 11.03B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 119.94B | -1.96% | 1,289,116 | 12.22B |
| 19 | SYK | Stryker Corporation | 118.55B | -1.70% | 2,152,328 | 25.27B |
| 20 | SNY | Sanofi | 105.42B | 0.09% | 2,827,823 | 54.60B |
| 21 | MDT | Medtronic plc | 104.82B | -0.56% | 4,666,902 | 36.36B |
| 22 | GSK | GSK plc | 101.79B | -0.04% | 3,976,765 | 43.29B |
| 23 | MCK | McKesson Corporation | 95.31B | -1.79% | 710,491 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 84.38B | -1.11% | 1,198,523 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 82.50B | -0.33% | 842,299 | 76.39B |
| 26 | CI | The Cigna Group | 75.35B | -1.94% | 1,411,503 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 66.25B | -3.56% | 872,114 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 63.87B | -0.51% | 11,201,157 | 20.61B |
| 29 | COR | Cencora, Inc. | 58.48B | -0.82% | 998,268 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 54.35B | -2.09% | 4,661,342 | 28.34B |
| 31 | ARGX | argenx SE | 54.15B | -2.63% | 213,322 | 4.74B |
| 32 | CAH | Cardinal Health, Inc. | 51.65B | -2.88% | 2,521,779 | 250.74B |
| 33 | MDLN | Medline Inc. | 48.84B | -4.89% | 5,663,015 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 48.58B | -0.21% | 4,512,282 | 6.30B |
| 35 | HUM | Humana Inc. | 47.74B | -1.67% | 689,791 | 137.20B |
| 36 | HLN | Haleon plc | 43.12B | -0.71% | 9,497,971 | 14.85B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 42.99B | -1.35% | 478,572 | 4.45B |
| 38 | BDX | Becton, Dickinson and Company | 42.20B | -0.44% | 1,162,412 | 22.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 38.91B | -0.14% | 888,630 | - |
| 40 | NTRA | Natera, Inc. | 37.84B | -1.11% | 807,067 | 2.50B |
| 41 | A | Agilent Technologies, Inc. | 37.69B | 0.45% | 2,662,806 | 7.23B |
| 42 | WAT | Waters Corporation | 36.41B | 0.89% | 956,682 | 3.77B |
| 43 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.65B | -1.61% | 1,104,477 | 4.29B |
| 44 | ONC | BeOne Medicines AG | 35.57B | 0.39% | 529,541 | 5.74B |
| 45 | TEVA | Teva Pharmaceutical Industries Limited | 35.11B | -3.83% | 5,116,995 | 17.35B |
| 46 | RPRX | Royalty Pharma plc | 33.81B | 0.51% | 2,618,833 | 2.44B |
| 47 | IQV | IQVIA Holdings Inc. | 33.13B | -1.54% | 1,004,230 | 16.63B |
| 48 | ALC | Alcon Inc. | 32.92B | - | 1,709,360 | 10.63B |
| 49 | CNC | Centene Corporation | 32.54B | -2.52% | 4,506,781 | 178.33B |
| 50 | ZTS | Zoetis Inc. | 31.10B | -1.54% | 4,680,669 | 9.53B |
| 51 | VEEV | Veeva Systems Inc. | 29.98B | -2.48% | 1,225,146 | 3.32B |
| 52 | BIIB | Biogen Inc. | 29.19B | -2.67% | 841,027 | 9.94B |
| 53 | ILMN | Illumina, Inc. | 28.88B | -0.86% | 1,551,501 | 4.39B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 27.93B | -1.02% | 3,058,673 | 20.98B |
| 55 | RMD | ResMed Inc. | 27.83B | -1.48% | 971,171 | 5.54B |
| 56 | DXCM | DexCom, Inc. | 27.56B | -4.44% | 3,870,838 | 4.82B |
| 57 | MTD | Mettler-Toledo International Inc. | 25.98B | -0.95% | 167,030 | 4.09B |
| 58 | PHG | Koninklijke Philips N.V. | 25.69B | -1.17% | 854,638 | 20.34B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.32B | -0.23% | 861,146 | 3.22B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.11B | -0.14% | 3,399,668 | 8.26M |
| 61 | DGX | Quest Diagnostics Incorporated | 23.23B | 1.45% | 1,834,055 | 11.28B |
| 62 | BNTX | BioNTech SE | 23.22B | -0.54% | 508,360 | 3.23B |
| 63 | INCY | Incyte Corporation | 23.13B | -1.36% | 998,326 | 5.36B |
| 64 | INSM | Insmed Incorporated | 23.11B | -1.82% | 1,771,215 | 819.56M |
| 65 | LH | Labcorp Holdings Inc. | 23.08B | 0.74% | 854,978 | 14.14B |
| 66 | MRNA | Moderna, Inc. | 23.04B | -2.67% | 3,780,416 | 2.23B |
| 67 | UTHR | United Therapeutics Corporation | 22.37B | -1.63% | 469,812 | 3.17B |
| 68 | STE | STERIS plc | 20.52B | -0.56% | 690,626 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 19.99B | -1.01% | 1,102,971 | 1.08B |
| 70 | VTRS | Viatris Inc. | 19.81B | -3.30% | 14,626,101 | 14.56B |
| 71 | GMAB | Genmab A/S | 17.91B | 1.69% | 1,852,886 | 3.90B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 17.36B | -3.55% | 1,191,771 | 3.10B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.16B | -0.27% | 1,179,140 | 8.41B |
| 74 | THC | Tenet Healthcare Corporation | 16.83B | -0.58% | 892,885 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 16.61B | -1.28% | 412,323 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.20B | 0.25% | 1,568,904 | 579.96M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.73B | -1.50% | 520,921 | 4.44B |
| 78 | MEDP | Medpace Holdings, Inc. | 15.08B | -0.67% | 523,068 | 2.78B |
| 79 | DVA | DaVita Inc. | 14.90B | -2.19% | 979,409 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.53B | -3.89% | 3,677,313 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 13.82B | -2.03% | 1,656,466 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.75B | -0.72% | 1,599,782 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.45B | -1.22% | 515,760 | 8.26B |
| 84 | FMS | Fresenius Medical Care AG | 12.96B | -1.54% | 431,283 | 22.32B |
| 85 | ICLR | ICON Public Limited Company | 12.81B | 0.40% | 568,059 | 8.27B |
| 86 | ELAN | Elanco Animal Health Incorporated | 12.66B | -0.55% | 5,322,019 | 4.89B |
| 87 | SNN | Smith & Nephew plc | 12.59B | -0.89% | 1,069,453 | 6.16B |
| 88 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.49B | 19.03% | 7,013,593 | 622.01M |
| 89 | PEN | Penumbra, Inc. | 12.45B | -0.28% | 640,408 | 1.45B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.40B | -1.67% | 310,894 | 1.13B |
| 91 | ALGN | Align Technology, Inc. | 12.35B | -2.84% | 511,828 | 4.10B |
| 92 | RVTY | Revvity, Inc. | 12.33B | 0.02% | 1,699,129 | 2.90B |
| 93 | AXSM | Axsome Therapeutics, Inc. | 12.33B | 1.13% | 648,267 | 708.24M |
| 94 | MOH | Molina Healthcare, Inc. | 11.55B | -2.12% | 2,185,656 | 42.66B |
| 95 | SMMT | Summit Therapeutics Inc. | 11.44B | 0.75% | 4,255,905 | - |
| 96 | ABVX | ABIVAX Société Anonyme | 11.35B | -3.25% | 699,870 | 5.67M |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.29B | -1.37% | 1,428,365 | 3.24B |
| 98 | BAX | Baxter International Inc. | 11.23B | -2.12% | 4,511,401 | 11.32B |
| 99 | TECH | Bio-Techne Corporation | 11.19B | 0.21% | 2,667,915 | 1.21B |
| 100 | CYTK | Cytokinetics, Incorporated | 11.16B | 1.33% | 2,072,222 | 105.82M |
| 101 | EHC | Encompass Health Corporation | 11.01B | -0.96% | 716,126 | 6.07B |
| 102 | PODD | Insulet Corporation | 11.01B | -2.93% | 1,376,157 | 2.90B |
| 103 | CRL | Charles River Laboratories International, Inc. | 10.53B | -0.32% | 570,782 | 4.03B |
| 104 | GMED | Globus Medical, Inc. | 10.25B | -0.78% | 982,777 | 3.10B |
| 105 | RDY | Dr. Reddy's Laboratories Limited | 10.21B | -9.39% | 4,326,646 | 3.50B |
| 106 | APGE | Apogee Therapeutics, Inc. | 10.07B | -0.09% | 1,411,011 | - |
| 107 | KRYS | Krystal Biotech, Inc. | 9.93B | -0.67% | 292,820 | 417.30M |
| 108 | ENSG | The Ensign Group, Inc. | 9.80B | -1.03% | 368,981 | 5.27B |
| 109 | CORT | Corcept Therapeutics Incorporated | 9.76B | -4.99% | 1,378,230 | 769.10M |
| 110 | HSIC | Henry Schein, Inc. | 9.66B | -1.22% | 1,196,882 | 13.38B |
| 111 | HALO | Halozyme Therapeutics, Inc. | 9.23B | -0.99% | 1,399,849 | 1.51B |
| 112 | BRKR | Bruker Corporation | 9.09B | -1.14% | 1,350,439 | 3.46B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.08B | -2.67% | 538,285 | 51.48M |
| 114 | UHS | Universal Health Services, Inc. | 9.04B | -0.38% | 549,797 | 17.76B |
| 115 | GKOS | Glaukos Corporation | 8.97B | -0.15% | 577,609 | 551.35M |
| 116 | IONS | Ionis Pharmaceuticals, Inc. | 8.93B | 1.16% | 8,748,142 | 1.06B |
| 117 | OSCR | Oscar Health, Inc. | 8.88B | -4.13% | 4,252,475 | 13.30B |
| 118 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | -0.21% | 4,935,034 | 18.07M |
| 119 | ALKS | Alkermes plc | 8.76B | -0.51% | 1,837,060 | 1.56B |
| 120 | SYRE | Spyre Therapeutics, Inc. | 8.72B | -3.44% | 596,102 | - |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 8.71B | -2.08% | 710,437 | 74.06M |
| 122 | PRAX | Praxis Precision Medicines, Inc. | 8.70B | -1.82% | 229,309 | 7.46M |
| 123 | TEM | Tempus AI, Inc. | 8.43B | -4.12% | 4,143,914 | 1.36B |
| 124 | QGEN | Qiagen N.V. | 8.39B | 0.10% | 2,398,053 | 2.10B |
| 125 | ATR | AptarGroup, Inc. | 8.24B | 0.20% | 309,906 | 3.87B |
| 126 | BIO | Bio-Rad Laboratories, Inc. | 8.19B | 1.41% | 275,066 | 2.59B |
| 127 | PCVX | Vaxcyte, Inc. | 8.09B | -3.51% | 1,036,068 | - |
| 128 | HQY | HealthEquity, Inc. | 8.02B | -1.86% | 587,219 | 1.34B |
| 129 | IMVT | Immunovant, Inc. | 8.02B | -1.21% | 767,312 | - |
| 130 | RGEN | Repligen Corporation | 7.90B | 2.26% | 2,702,830 | 763.34M |
| 131 | IBRX | ImmunityBio, Inc. | 7.87B | -6.94% | 8,880,733 | 140.98M |
| 132 | LQDA | Liquidia Corporation | 7.74B | 7.60% | 3,398,448 | 288.07M |
| 133 | AVTR | Avantor, Inc. | 7.48B | -0.36% | 7,261,912 | 6.55B |
| 134 | TGTX | TG Therapeutics, Inc. | 7.47B | -2.35% | 1,334,823 | 700.35M |
| 135 | HIMS | Hims & Hers Health, Inc. | 7.33B | -3.21% | 8,314,506 | 2.37B |
| 136 | PACS | PACS Group, Inc. | 7.13B | -1.10% | 850,709 | 5.43B |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.13B | -2.47% | 414,326 | 217.17M |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 6.98B | -2.20% | 441,955 | 569.61M |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.81B | -3.09% | 452,357 | 1.55B |
| 140 | ERAS | Erasca, Inc. | 6.77B | 0.67% | 3,076,573 | - |
| 141 | COGT | Cogent Biosciences, Inc. | 6.76B | -0.25% | 1,941,813 | - |
| 142 | GRFS | Grifols, S.A. | 6.74B | 1.68% | 381,900 | 8.58B |
| 143 | CHE | Chemed Corporation | 6.66B | -0.12% | 210,434 | 2.54B |
| 144 | PTCT | PTC Therapeutics, Inc. | 6.50B | -0.13% | 583,882 | 827.11M |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.40B | -0.84% | 593,539 | 7.50M |
| 146 | BLTE | Belite Bio, Inc | 6.18B | -2.45% | 152,043 | - |
| 147 | HNGE | Hinge Health, Inc. | 6.12B | -6.25% | 2,189,974 | 646.34M |
| 148 | CGON | CG Oncology, Inc. | 6.11B | -3.36% | 663,630 | 5.07M |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 6.03B | -0.40% | 205,457 | 274.48M |
| 150 | TXG | 10x Genomics, Inc. | 5.97B | -0.32% | 2,822,538 | 638.78M |
| 151 | TFX | Teleflex Incorporated | 5.97B | -0.16% | 343,952 | 2.13B |
| 152 | BLLN | BillionToOne, Inc. | 5.94B | -2.48% | 533,499 | 354.54M |
| 153 | TWST | Twist Bioscience Corporation | 5.87B | -1.72% | 1,089,678 | 409.48M |
| 154 | DFTX | Definium Therapeutics, Inc. | 5.80B | -3.13% | 1,239,644 | - |
| 155 | SRRK | Scholar Rock Holding Corporation | 5.79B | -5.07% | 1,607,900 | - |
| 156 | BLCO | Bausch + Lomb Corporation | 5.69B | -0.25% | 447,128 | 5.21B |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.66B | -1.93% | 1,278,978 | 3.05B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 5.62B | -2.80% | 1,028,655 | 1.34M |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.58B | -1.90% | 728,909 | - |
| 160 | STVN | Stevanato Group S.p.A. | 5.29B | 1.41% | 212,223 | 1.39B |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.23B | -0.57% | 920,897 | 536.20M |
| 162 | INDV | Indivior Pharmaceuticals, Inc. | 4.93B | - | 968,091 | 1.29B |
| 163 | SHC | Sotera Health Company | 4.93B | -0.63% | 2,598,048 | 1.19B |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.80B | -1.75% | 328,308 | 754.05M |
| 165 | RDNT | RadNet, Inc. | 4.66B | -4.28% | 525,938 | 2.14B |
| 166 | CRSP | CRISPR Therapeutics AG | 4.65B | -1.89% | 2,449,151 | 4.10M |
| 167 | VCYT | Veracyte, Inc. | 4.63B | -2.55% | 610,075 | 541.74M |
| 168 | MANE | Veradermics, Incorporated | 4.59B | 0.33% | 350,155 | - |
| 169 | MMED | MiniMed Group, Inc. | 4.59B | -2.22% | 968,998 | 3.10B |
| 170 | LEGN | Legend Biotech Corporation | 4.55B | -0.04% | 1,551,771 | 1.14B |
| 171 | CELC | Celcuity Inc. | 4.40B | -1.69% | 792,924 | - |
| 172 | MMSI | Merit Medical Systems, Inc. | 4.36B | -0.50% | 484,878 | 1.54B |
| 173 | CAI | Caris Life Sciences, Inc. | 4.35B | -2.23% | 1,990,877 | 907.29M |
| 174 | VKTX | Viking Therapeutics, Inc. | 4.33B | -1.69% | 1,346,994 | - |
| 175 | NVST | Envista Holdings Corporation | 4.30B | -1.86% | 1,934,030 | 2.81B |
| 176 | LIVN | LivaNova PLC | 4.30B | -1.98% | 434,566 | 1.43B |
| 177 | ALHC | Alignment Healthcare, Inc. | 4.29B | -3.40% | 3,369,102 | 4.26B |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 4.27B | -1.85% | 1,163,324 | 1.10B |
| 179 | LFST | LifeStance Health Group, Inc. | 4.27B | -3.84% | 2,175,940 | 1.49B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.20B | -0.16% | 1,321,143 | 10.68M |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 4.12B | -3.16% | 593,192 | - |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.06B | -3.17% | 1,243,821 | 56.99M |
| 183 | CON | Concentra Group Holdings Parent, Inc. | 4.00B | -1.60% | 763,164 | 2.23B |
| 184 | WAY | Waystar Holding Corp. | 3.99B | -3.35% | 1,819,244 | 1.16B |
| 185 | ICUI | ICU Medical, Inc. | 3.93B | -0.84% | 154,870 | 2.16B |
| 186 | PBLS | Parabilis Medicines, Inc. | 3.92B | 2.56% | 317,825 | - |
| 187 | DYN | Dyne Therapeutics, Inc. | 3.84B | -2.60% | 9,159,995 | - |
| 188 | RCUS | Arcus Biosciences, Inc. | 3.77B | 1.66% | 1,035,308 | 236.00M |
| 189 | DNLI | Denali Therapeutics Inc. | 3.75B | -0.80% | 1,321,439 | - |
| 190 | NAMS | NewAmsterdam Pharma Company N.V. | 3.71B | -1.98% | 702,045 | 22.57M |
| 191 | ELVN | Enliven Therapeutics, Inc. | 3.69B | -2.72% | 448,074 | - |
| 192 | DOCS | Doximity, Inc. | 3.68B | -2.94% | 2,658,983 | 644.86M |
| 193 | ALMS | Alumis Inc. | 3.67B | -4.13% | 813,387 | 8.40M |
| 194 | GPCR | Structure Therapeutics Inc. | 3.58B | 2.15% | 616,181 | - |
| 195 | OGN | Organon & Co. | 3.55B | 0.07% | 2,486,828 | 6.16B |
| 196 | HAE | Haemonetics Corporation | 3.55B | -0.05% | 363,405 | 1.33B |
| 197 | TLX | Telix Pharmaceuticals Limited | 3.53B | -5.49% | 222,352 | 803.79M |
| 198 | ADPT | Adaptive Biotechnologies Corporation | 3.51B | -2.79% | 2,355,574 | 295.41M |
| 199 | BKD | Brookdale Senior Living Inc. | 3.50B | -3.55% | 3,890,616 | 3.00B |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.49B | -1.27% | 802,449 | 415.62M |
| 201 | IRTC | iRhythm Holdings, Inc. | 3.49B | -2.69% | 334,405 | 787.85M |
| 202 | NHC | National HealthCare Corporation | 3.44B | -1.13% | 91,039 | 1.53B |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 3.33B | -2.75% | 564,233 | 225.27M |
| 204 | OPCH | Option Care Health, Inc. | 3.32B | -2.40% | 1,475,962 | 5.67B |
| 205 | ITGR | Integer Holdings Corporation | 3.28B | 0.26% | 215,625 | 1.86B |
| 206 | ACHC | Acadia Healthcare Company, Inc. | 3.20B | -2.33% | 1,412,717 | 3.37B |
| 207 | PRVA | Privia Health Group, Inc. | 3.20B | -3.57% | 957,204 | 2.25B |
| 208 | GRAL | GRAIL, Inc. | 3.03B | -2.82% | 321,904 | 156.12M |
| 209 | WRBY | Warby Parker Inc. | 3.01B | -0.20% | 3,248,055 | 890.57M |
| 210 | RGC | Regencell Bioscience Holdings Limited | 2.96B | -1.32% | 285,794 | - |
| 211 | IRON | Disc Medicine, Inc. | 2.84B | -1.67% | 268,023 | - |
| 212 | QURE | uniQure N.V. | 2.78B | 0.72% | 1,053,756 | 18.09M |
| 213 | MBX | MBX Biosciences, Inc. | 2.77B | -3.28% | 696,098 | - |
| 214 | ESTA | Establishment Labs Holdings Inc. | 2.76B | -1.86% | 300,745 | 229.58M |
| 215 | CLDX | Celldex Therapeutics, Inc. | 2.73B | -2.50% | 1,928,818 | 865.00K |
| 216 | SUPN | Supernus Pharmaceuticals, Inc. | 2.72B | -1.94% | 430,059 | 776.83M |
| 217 | RARE | Ultragenyx Pharmaceutical Inc. | 2.71B | -3.41% | 1,546,483 | 670.00M |
| 218 | XRAY | DENTSPLY SIRONA Inc. | 2.66B | -2.78% | 4,935,624 | 3.68B |
| 219 | ATAI | AtaiBeckley Inc. | 2.66B | 0.56% | 10,979,654 | 3.49M |
| 220 | BEAM | Beam Therapeutics Inc. | 2.65B | -2.38% | 1,544,146 | 164.01M |
| 221 | KOD | Kodiak Sciences Inc. | 2.62B | -1.18% | 435,332 | - |
| 222 | IMNM | Immunome, Inc. | 2.59B | 0.44% | 628,234 | 4.02M |
| 223 | VERA | Vera Therapeutics, Inc. | 2.59B | -3.00% | 1,124,390 | - |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.52B | -2.79% | 162,645 | 1.46B |
| 225 | TARS | Tarsus Pharmaceuticals, Inc. | 2.48B | 0.56% | 1,283,013 | 535.08M |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.46B | -4.51% | 1,296,650 | - |
| 227 | TMDX | TransMedics Group, Inc. | 2.46B | -4.16% | 847,939 | 635.89M |
| 228 | CLOV | Clover Health Investments, Corp. | 2.46B | -2.51% | 3,668,197 | 2.21B |
| 229 | PGNY | Progyny, Inc. | 2.46B | -2.76% | 969,541 | 1.29B |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.45B | 0.51% | 1,130,593 | 36.77M |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.42B | 0.96% | 2,550,091 | 885.72M |
| 232 | PHVS | Pharvaris N.V. | 2.40B | -0.26% | 283,965 | - |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | -1.85% | 506,855 | - |
| 234 | SLS | SELLAS Life Sciences Group, Inc. | 2.38B | -6.36% | 5,340,361 | - |
| 235 | NKTR | Nektar Therapeutics | 2.34B | 0.95% | 508,624 | 55.63M |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.32B | -0.02% | 362,552 | 1.09B |
| 237 | IOVA | Iovance Biotherapeutics, Inc. | 2.31B | -5.66% | 14,160,811 | 285.61M |
| 238 | KLRA | Kailera Therapeutics, Inc. | 2.30B | -3.37% | 646,833 | - |
| 239 | ZLAB | Zai Lab Limited | 2.30B | 0.10% | 248,361 | 453.28M |
| 240 | COAG | Hemab Therapeutics Holdings, Inc. | 2.30B | 1.97% | 240,607 | - |
| 241 | NUVB | Nuvation Bio Inc. | 2.28B | 1.87% | 7,707,005 | 143.05M |
| 242 | VCEL | Vericel Corporation | 2.28B | -3.42% | 383,699 | 292.09M |
| 243 | PLSE | Pulse Biosciences, Inc. | 2.27B | 8.26% | 592,487 | 751.00K |
| 244 | LMAT | LeMaitre Vascular, Inc. | 2.26B | -1.79% | 287,550 | 256.28M |
| 245 | BHVN | Biohaven Ltd. | 2.22B | -4.90% | 2,169,528 | - |
| 246 | AGIO | Agios Pharmaceuticals, Inc. | 2.14B | -3.51% | 902,946 | 66.05M |
| 247 | NEOG | Neogen Corporation | 2.14B | -1.01% | 1,184,175 | 870.56M |
| 248 | MESO | Mesoblast Limited | 2.13B | -0.73% | 166,090 | 65.38M |
| 249 | VRDN | Viridian Therapeutics, Inc. | 2.12B | -0.05% | 2,622,767 | 70.92M |
| 250 | AXGN | Axogen, Inc. | 2.09B | -2.21% | 982,848 | 238.11M |
| 251 | HTFL | HeartFlow, Inc. | 2.09B | -4.76% | 1,114,095 | 191.42M |
| 252 | MD | Pediatrix Medical Group, Inc. | 2.07B | -1.19% | 577,508 | 1.93B |
| 253 | AVAH | Aveanna Healthcare Holdings Inc. | 2.05B | -3.18% | 1,516,992 | 2.52B |
| 254 | URGN | UroGen Pharma Ltd. | 2.05B | -3.93% | 486,828 | 140.49M |
| 255 | KARD | Kardigan, Inc. | 2.04B | -0.22% | 309,843 | - |
| 256 | PVLA | Palvella Therapeutics, Inc. | 2.04B | -1.22% | 143,560 | - |
| 257 | ADUS | Addus HomeCare Corporation | 2.04B | -1.69% | 194,382 | 1.45B |
| 258 | SION | Sionna Therapeutics, Inc. | 2.03B | -4.62% | 562,845 | - |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 2.02B | -5.37% | 857,202 | 899.11M |
| 260 | NBTX | Nanobiotix S.A. | 2.01B | 2.44% | 89,703 | 38.27M |
| 261 | GLUE | Monte Rosa Therapeutics, Inc. | 2.01B | 0.68% | 734,563 | 42.95M |
| 262 | AGL | agilon health, inc. | 2.00B | -4.69% | 237,533 | 5.82B |
| 263 | HCM | HUTCHMED (China) Limited | 1.99B | -0.54% | 75,082 | 548.51M |
| 264 | ZBIO | Zenas BioPharma, Inc. | 1.99B | -2.69% | 1,246,532 | 10.00M |
| 265 | RAPP | Rapport Therapeutics, Inc. | 1.98B | -2.89% | 243,689 | 20.00M |
| 266 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -1.98% | 838,340 | 298.30M |
| 267 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.97B | -4.32% | 1,562,295 | -665.00K |
| 268 | SGRY | Surgery Partners, Inc. | 1.96B | -7.06% | 1,499,675 | 3.34B |
| 269 | GHRS | GH Research PLC | 1.96B | 0.81% | 147,497 | - |
| 270 | SNDX | Syndax Pharmaceuticals, Inc. | 1.95B | -2.61% | 1,059,690 | 217.17M |
| 271 | CDNA | CareDx, Inc. | 1.95B | -1.97% | 1,034,391 | 412.82M |
| 272 | ADMA | ADMA Biologics, Inc. | 1.94B | -2.44% | 1,986,376 | 509.86M |
| 273 | LKFT | Lakefront Biotherapeutics NV | 1.93B | -1.54% | 106,343 | 1.20B |
| 274 | PGEN | Precigen, Inc. | 1.90B | -3.10% | 3,036,576 | 31.60M |
| 275 | ASTH | Astrana Health, Inc. | 1.89B | -7.74% | 574,926 | 3.53B |
| 276 | OCUL | Ocular Therapeutix, Inc. | 1.88B | -3.86% | 1,865,664 | 52.04M |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.87B | -3.47% | 326,229 | 367.34M |
| 278 | WGS | GeneDx Holdings Corp. | 1.86B | 1.54% | 723,471 | 442.68M |
| 279 | OMCL | Omnicell, Inc. | 1.86B | -2.32% | 647,005 | 1.23B |
| 280 | DMRA | Damora Therapeutics, Inc. | 1.85B | -9.09% | 587,259 | - |
| 281 | UFPT | UFP Technologies, Inc. | 1.84B | -2.45% | 143,014 | 608.85M |
| 282 | BCAX | Bicara Therapeutics Inc. | 1.84B | -0.67% | 385,565 | - |
| 283 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.83B | - | 2,413,024 | 204.73M |
| 284 | NEO | NeoGenomics, Inc. | 1.82B | -3.04% | 1,708,710 | 745.97M |
| 285 | TYRA | Tyra Biosciences, Inc. | 1.82B | -3.96% | 470,558 | - |
| 286 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | -0.18% | 1,728,846 | 7.47M |
| 287 | IMCR | Immunocore Holdings plc | 1.81B | 3.07% | 733,234 | 412.81M |
| 288 | STOK | Stoke Therapeutics, Inc. | 1.80B | 0.52% | 416,624 | 32.08M |
| 289 | NVCR | NovoCure Limited | 1.80B | -2.69% | 1,064,780 | 674.41M |
| 290 | GENB | Generate Biomedicines, Inc. | 1.78B | -3.41% | 271,367 | 30.30M |
| 291 | AAPG | Ascentage Pharma Group International | 1.76B | 0.71% | 11,598 | 82.08M |
| 292 | ABCL | AbCellera Biologics Inc. | 1.75B | -4.02% | 2,559,199 | 79.21M |
| 293 | FTRE | Fortrea Holdings Inc. | 1.75B | 3.24% | 1,159,078 | 2.71B |
| 294 | ALMR | Alamar Biosciences, Inc. | 1.74B | -0.12% | 199,449 | 87.16M |
| 295 | BFLY | Butterfly Network, Inc. | 1.73B | -3.08% | 8,485,152 | 102.92M |
| 296 | BHC | Bausch Health Companies Inc. | 1.70B | 0.88% | 1,613,406 | 10.53B |
| 297 | ATRC | AtriCure, Inc. | 1.70B | -2.87% | 713,204 | 552.16M |
| 298 | ZYME | Zymeworks Inc. | 1.67B | -2.87% | 387,993 | 81.26M |
| 299 | SRPT | Sarepta Therapeutics, Inc. | 1.67B | -2.41% | 2,426,944 | 2.18B |
| 300 | TRLV | Trulieve Cannabis Corp. | 1.67B | -3.24% | 421,859 | 1.17B |
| 301 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -1.95% | 203,455 | 923.71M |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.62B | -5.00% | 1,684,303 | 1.86B |
| 303 | TDOC | Teladoc Health, Inc. | 1.61B | -8.14% | 4,785,372 | 2.51B |
| 304 | CMPS | COMPASS Pathways plc | 1.61B | -2.05% | 1,726,275 | - |
| 305 | MPLT | MapLight Therapeutics, Inc. | 1.60B | -5.69% | 265,913 | - |
| 306 | HROW | Harrow, Inc. | 1.60B | -2.01% | 382,671 | 268.68M |
| 307 | INNV | InnovAge Holding Corp. | 1.59B | -1.35% | 266,400 | 949.17M |
| 308 | INVA | Innoviva, Inc. | 1.58B | -0.70% | 482,088 | 420.69M |
| 309 | RXRX | Recursion Pharmaceuticals, Inc. | 1.58B | -3.25% | 15,209,127 | 66.41M |
| 310 | VIR | Vir Biotechnology, Inc. | 1.58B | -0.74% | 1,451,556 | 65.50M |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.58B | -2.76% | 247,774 | 20.00M |
| 312 | MLTX | MoonLake Immunotherapeutics | 1.56B | -5.58% | 1,137,606 | - |
| 313 | ANAB | AnaptysBio, Inc. | 1.56B | -2.14% | 986,958 | 232.39M |
| 314 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -2.96% | 2,378,876 | 66.09M |
| 315 | SEPN | Septerna, Inc. | 1.54B | 1.54% | 264,140 | 72.26M |
| 316 | ENOV | Enovis Corporation | 1.53B | -2.03% | 498,037 | 2.28B |
| 317 | BLFS | BioLife Solutions, Inc. | 1.52B | 6.71% | 9,937,932 | 101.66M |
| 318 | XERS | Xeris Biopharma Holdings, Inc. | 1.52B | -4.56% | 2,260,121 | 314.85M |
| 319 | ARDT | Ardent Health, Inc. | 1.49B | -0.77% | 281,642 | 6.43B |
| 320 | IART | Integra LifeSciences Holdings Corporation | 1.46B | -1.00% | 802,794 | 1.64B |
| 321 | INSP | Inspire Medical Systems, Inc. | 1.45B | -3.98% | 755,921 | 915.25M |
| 322 | PRGO | Perrigo Company plc | 1.45B | - | 2,798,514 | 4.18B |
| 323 | AHCO | AdaptHealth Corp. | 1.45B | -2.94% | 917,225 | 3.29B |
| 324 | XNCR | Xencor, Inc. | 1.45B | -4.60% | 1,259,653 | 97.36M |
| 325 | SVRA | Savara Inc. | 1.43B | -3.25% | 3,405,818 | - |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.42B | 7.71% | 694,868 | - |
| 327 | PNTG | The Pennant Group, Inc. | 1.41B | -2.46% | 229,050 | 1.02B |
| 328 | ABSI | Absci Corporation | 1.40B | -0.96% | 1,846,582 | 1.84M |
| 329 | FBRX | Forte Biosciences, Inc. | 1.38B | 11.63% | 530,621 | - |
| 330 | PAHC | Phibro Animal Health Corporation | 1.37B | -0.15% | 158,809 | 1.50B |
| 331 | AKTS | Aktis Oncology, Inc. | 1.37B | 0.73% | 208,003 | 8.28M |
| 332 | TRAX | First Tracks Biotherapeutics, Inc. | 1.33B | 2.14% | 585,779 | - |
| 333 | AMN | AMN Healthcare Services, Inc. | 1.33B | -0.03% | 429,583 | 3.42B |
| 334 | PSNL | Personalis, Inc. | 1.31B | -7.22% | 4,044,991 | 64.52M |
| 335 | NVAX | Novavax, Inc. | 1.30B | -2.10% | 2,637,230 | 596.34M |
| 336 | OMDA | Omada Health, Inc. | 1.30B | -5.00% | 1,102,204 | 283.30M |
| 337 | AVLN | Avalyn Pharma Inc. | 1.27B | -1.07% | 293,985 | - |
| 338 | CNMD | CONMED Corporation | 1.26B | 0.29% | 636,434 | 1.37B |
| 339 | INBX | Inhibrx Biosciences, Inc. | 1.26B | -1.93% | 150,484 | 1.30M |
| 340 | ARDX | Ardelyx, Inc. | 1.25B | -0.20% | 2,179,711 | 427.68M |
| 341 | IMTX | Immatics N.V. | 1.25B | -2.55% | 249,734 | 43.00M |
| 342 | AZTA | Azenta, Inc. | 1.25B | 2.14% | 498,418 | 596.48M |
| 343 | ATEC | Alphatec Holdings, Inc. | 1.24B | -2.89% | 2,089,871 | 787.08M |
| 344 | AHG | Akso Health Group | 1.23B | -10.00% | 6,136 | 14.84M |
| 345 | STAA | STAAR Surgical Company | 1.23B | 1.81% | 876,045 | 290.38M |
| 346 | KMTS | Kestra Medical Technologies, Ltd. | 1.22B | -6.07% | 424,429 | 95.13M |
| 347 | AORT | Artivion, Inc. | 1.22B | 0.80% | 422,281 | 458.69M |
| 348 | IRMD | IRADIMED CORPORATION | 1.20B | -0.94% | 91,868 | 86.28M |
| 349 | ETON | Eton Pharmaceuticals, Inc. | 1.19B | 0.88% | 584,422 | 86.93M |
| 350 | MNKD | MannKind Corporation | 1.19B | -5.19% | 5,542,955 | 360.78M |
| 351 | JBIO | Jade Biosciences, Inc. | 1.18B | -3.31% | 782,800 | - |
| 352 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -3.32% | 551,257 | - |
| 353 | DRTS | Alpha Tau Medical Ltd. | 1.17B | -2.33% | 666,286 | - |
| 354 | AVNS | Avanos Medical, Inc. | 1.17B | - | 588,190 | 715.90M |
| 355 | TNDM | Tandem Diabetes Care, Inc. | 1.16B | -3.92% | 1,533,783 | 1.03B |
| 356 | SPTX | Seaport Therapeutics, Inc. | 1.14B | 1.43% | 73,289 | - |
| 357 | ALVO | Alvotech | 1.14B | -9.38% | 1,476,739 | 562.04M |
| 358 | QDEL | QuidelOrtho Corporation | 1.14B | 1.52% | 1,257,017 | 2.66B |
| 359 | USPH | U.S. Physical Therapy, Inc. | 1.13B | -0.48% | 197,213 | 787.69M |
| 360 | MGTX | MeiraGTx Holdings plc | 1.13B | -2.88% | 383,021 | 79.76M |
| 361 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | -3.15% | 231,336 | 796.33M |
| 362 | SDGR | Schrödinger, Inc. | 1.12B | -0.46% | 650,751 | 254.91M |
| 363 | ORIC | ORIC Pharmaceuticals, Inc. | 1.11B | -0.74% | 1,037,310 | - |
| 364 | WVE | Wave Life Sciences Ltd. | 1.10B | -0.86% | 2,134,413 | 71.80M |
| 365 | CAPR | Capricor Therapeutics, Inc. | 1.10B | -4.45% | 1,542,360 | 11.13M |
| 366 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | -2.27% | 494,334 | - |
| 367 | NUTX | Nutex Health Inc. | 1.08B | -6.57% | 110,955 | 879.95M |
| 368 | CERT | Certara, Inc. | 1.07B | 0.58% | 2,072,663 | 419.75M |
| 369 | EYPT | EyePoint, Inc. | 1.06B | -2.99% | 1,063,953 | 7.61M |
| 370 | ANRO | Alto Neuroscience, Inc. | 1.06B | 0.59% | 395,006 | - |
| 371 | VOR | Vor Biopharma Inc. | 1.06B | -2.69% | 1,009,975 | - |
| 372 | IVA | Inventiva S.A. | 1.04B | 1.34% | 542,161 | 7.94M |
| 373 | CRON | Cronos Group Inc. | 1.04B | -0.71% | 890,587 | 159.54M |
| 374 | LBRX | LB Pharmaceuticals Inc | 1.03B | 10.93% | 799,241 | - |
| 375 | LMRI | Lumexa Imaging Holdings, Inc. | 1.02B | -4.31% | 233,480 | 1.03B |
| 376 | PRCT | PROCEPT BioRobotics Corporation | 1.01B | -4.43% | 1,138,190 | 322.02M |
| 377 | PCRX | Pacira BioSciences, Inc. | 1.01B | -0.74% | 428,576 | 734.86M |
| 378 | OLMA | Olema Pharmaceuticals, Inc. | 1.00B | -0.86% | 681,568 | - |
| 379 | LXRX | Lexicon Pharmaceuticals, Inc. | 999.44M | -5.46% | 3,601,885 | 69.64M |
| 380 | GMRS | GMR Solutions Inc. | 994.71M | -1.46% | 209,670 | 5.83B |
| 381 | GDRX | GoodRx Holdings, Inc. | 992.32M | -2.98% | 682,695 | 787.89M |
| 382 | BIOA | BioAge Labs, Inc. | 975.29M | -3.13% | 864,047 | 10.32M |
| 383 | BVS | Bioventus Inc. | 971.51M | -2.10% | 566,068 | 576.30M |
| 384 | AVTX | Avalo Therapeutics, Inc. | 960.19M | -3.56% | 664,693 | 59.00K |
| 385 | JANX | Janux Therapeutics, Inc. | 952.58M | -3.94% | 950,761 | 13.73M |
| 386 | SANA | Sana Biotechnology, Inc. | 935.69M | -1.27% | 1,756,138 | - |
| 387 | KURA | Kura Oncology, Inc. | 935.68M | -3.21% | 849,930 | 71.64M |
| 388 | PHAT | Phathom Pharmaceuticals, Inc. | 929.33M | 4.00% | 1,424,121 | 204.89M |
| 389 | PHAR | Pharming Group N.V. | 920.50M | -1.29% | 2,120 | 369.49M |
| 390 | GERN | Geron Corporation | 904.54M | -2.08% | 5,693,299 | 196.12M |
| 391 | REPL | Replimune Group, Inc. | 902.41M | -2.27% | 1,625,956 | - |
| 392 | GLAS | Glass House Brands Inc. | 895.84M | -1.86% | 121,091 | 177.68M |
| 393 | ODTX | Odyssey Therapeutics, Inc. | 891.01M | 2.14% | 171,113 | 1.06M |
| 394 | OPK | OPKO Health, Inc. | 891.01M | -2.48% | 3,591,182 | 581.12M |
| 395 | INMD | InMode Ltd. | 873.71M | -1.04% | 373,532 | 374.64M |
| 396 | TALK | Talkspace, Inc. | 872.74M | -0.19% | 1,846,909 | 238.37M |
| 397 | TBPH | Theravance Biopharma, Inc. | 871.23M | -0.18% | 690,036 | 109.78M |
| 398 | ANNX | Annexon, Inc. | 856.90M | -2.97% | 1,619,772 | - |
| 399 | ABUS | Arbutus Biopharma Corporation | 855.34M | -4.20% | 1,432,483 | 191.45M |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 850.99M | -1.48% | 409,241 | 720.53M |
| 401 | DBVT | DBV Technologies S.A. | 828.78M | -4.15% | 210,351 | 5.04M |
| 402 | AVR | Anteris Technologies Global Corp. | 813.75M | -1.65% | 550,034 | 1.85M |
| 403 | SLDB | Solid Biosciences Inc. | 797.44M | -4.26% | 964,854 | - |
| 404 | HSTM | HealthStream, Inc. | 785.60M | -3.41% | 236,389 | 311.78M |
| 405 | ACRS | Aclaris Therapeutics, Inc. | 784.91M | -1.23% | 963,864 | 8.37M |
| 406 | AURA | Aura Biosciences, Inc. | 773.20M | -0.28% | 411,906 | - |
| 407 | TENX | Tenax Therapeutics, Inc. | 755.65M | -5.92% | 1,644,589 | - |
| 408 | MNPR | Monopar Therapeutics Inc. | 753.48M | -0.96% | 439,752 | - |
| 409 | CSTL | Castle Biosciences, Inc. | 752.49M | 1.22% | 437,920 | 339.92M |
| 410 | SIBN | SI-BONE, Inc. | 741.08M | -1.94% | 408,079 | 206.22M |
| 411 | DRUG | Bright Minds Biosciences Inc. | 740.12M | -2.37% | 172,184 | - |
| 412 | CADL | Candel Therapeutics, Inc. | 739.30M | -1.27% | 779,562 | - |
| 413 | FTH | Faeth Therapeutics, Inc. | 738.82M | 1.02% | 441,901 | - |
| 414 | DSGN | Design Therapeutics, Inc. | 735.74M | -2.32% | 469,818 | - |
| 415 | BBNX | Beta Bionics, Inc. | 726.80M | -7.43% | 1,386,633 | 110.24M |
| 416 | CTMX | CytomX Therapeutics, Inc. | 724.95M | -2.63% | 2,312,865 | 35.54M |
| 417 | CLYM | Climb Bio, Inc. | 720.34M | -3.97% | 663,405 | - |
| 418 | NGNE | Neurogene Inc. | 719.56M | -1.55% | 130,233 | 925.00K |
| 419 | ZVRA | Zevra Therapeutics, Inc. | 717.66M | -2.49% | 941,392 | 122.29M |
| 420 | SSII | SS Innovations International, Inc. | 716.47M | - | 16,596 | 48.47M |
| 421 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 712.95M | 2.06% | 308,006 | - |
| 422 | OMER | Omeros Corporation | 712.17M | 3.25% | 1,229,959 | 9.89M |
| 423 | EVO | Evotec SE | 702.32M | -2.50% | 23,756 | 859.03M |
| 424 | RIGL | Rigel Pharmaceuticals, Inc. | 699.38M | -3.84% | 331,741 | 299.77M |
| 425 | OCS | Oculis Holding AG | 690.24M | -4.43% | 293,041 | 1.40M |
| 426 | SGP | SpyGlass Pharma, Inc. | 686.72M | 1.33% | 91,888 | - |
| 427 | IMMX | Immix Biopharma, Inc. | 669.90M | -1.67% | 1,801,545 | - |
| 428 | GYRE | Gyre Therapeutics, Inc. | 662.24M | -1.98% | 86,298 | 117.05M |
| 429 | BWAY | BrainsWay Ltd. | 654.34M | 2.54% | 126,510 | 56.22M |
| 430 | CBIO | Crescent Biopharma, Inc. | 654.16M | -4.87% | 347,556 | 11.88M |
| 431 | ACHV | Achieve Life Sciences, Inc. | 647.78M | -2.92% | 749,936 | - |
| 432 | ALLO | Allogene Therapeutics, Inc. | 641.99M | 0.54% | 4,135,067 | 22.00K |
| 433 | IRWD | Ironwood Pharmaceuticals, Inc. | 638.70M | -0.77% | 1,052,633 | 361.51M |
| 434 | CBLL | CeriBell, Inc. | 638.20M | -5.98% | 523,545 | 95.07M |
| 435 | RGNX | REGENXBIO Inc. | 629.37M | -1.35% | 1,153,445 | 87.82M |
| 436 | EVH | Evolent Health, Inc. | 626.52M | -4.79% | 1,631,594 | 1.89B |
| 437 | TCMD | Tactile Systems Technology, Inc. | 623.00M | -2.85% | 241,233 | 343.52M |
| 438 | CRMD | CorMedix Inc. | 622.91M | -3.05% | 859,552 | 400.05M |
| 439 | MDXG | MiMedx Group, Inc. | 621.10M | -3.47% | 1,069,511 | 389.42M |
| 440 | PHR | Phreesia, Inc. | 618.74M | -5.57% | 691,366 | 495.59M |
| 441 | NVCT | Nuvectis Pharma, Inc. | 608.13M | 1.10% | 157,318 | - |
| 442 | CERS | Cerus Corporation | 605.11M | -3.21% | 2,186,376 | 216.56M |
| 443 | SPRY | ARS Pharmaceuticals, Inc. | 601.78M | -4.72% | 3,117,359 | 98.99M |
| 444 | TECX | Tectonic Therapeutic, Inc. | 596.08M | -3.69% | 127,714 | - |
| 445 | CTKB | Cytek Biosciences, Inc. | 586.31M | -0.66% | 514,798 | 204.17M |
| 446 | FDMT | 4D Molecular Therapeutics, Inc. | 572.95M | -3.69% | 717,171 | 88.24M |
| 447 | AGMB | AgomAb Therapeutics NV | 571.28M | -0.34% | 84,537 | - |
| 448 | ANGO | AngioDynamics, Inc. | 571.21M | -2.81% | 405,351 | 320.17M |
| 449 | SLN | Silence Therapeutics plc | 558.78M | 9.03% | 847,366 | 839.00K |
| 450 | PRME | Prime Medicine, Inc. | 558.11M | -0.96% | 2,181,914 | 4.03M |
| 451 | FLGT | Fulgent Genetics, Inc. | 554.66M | -1.76% | 240,549 | 320.35M |
| 452 | CTNM | Contineum Therapeutics, Inc. | 550.70M | 5.97% | 268,271 | - |
| 453 | ALT | Altimmune, Inc. | 546.47M | -0.35% | 2,290,537 | 36.00K |
| 454 | SLBT | SL Science Holding Limited | 540.64M | -11.04% | 109,358 | 3.36M |
| 455 | STTK | Shattuck Labs, Inc. | 538.30M | -2.64% | 931,199 | 1.00M |
| 456 | SOPH | SOPHiA GENETICS SA | 536.93M | -1.54% | 493,633 | 81.18M |
| 457 | MYGN | Myriad Genetics, Inc. | 534.58M | -4.23% | 627,402 | 829.00M |
| 458 | ARVN | Arvinas, Inc. | 532.95M | - | 642,472 | 89.40M |
| 459 | ANL | Adlai Nortye Ltd. | 530.40M | 2.00% | 180,171 | 5.00M |
| 460 | TOI | The Oncology Institute, Inc. | 528.91M | -2.58% | 1,613,542 | 545.76M |
| 461 | RLMD | Relmada Therapeutics, Inc. | 524.45M | -5.66% | 1,548,596 | - |
| 462 | RZLT | Rezolute, Inc. | 522.33M | -1.77% | 854,105 | - |
| 463 | EIKN | Eikon Therapeutics, Inc. | 520.27M | -3.03% | 290,611 | - |
| 464 | VSTM | Verastem, Inc. | 517.58M | -1.83% | 1,342,841 | 49.59M |
| 465 | ASMB | Assembly Biosciences, Inc. | 516.04M | -1.62% | 128,330 | 71.10M |
| 466 | ZURA | Zura Bio Limited | 512.99M | -4.93% | 498,333 | - |
| 467 | DNA | Ginkgo Bioworks Holdings, Inc. | 511.49M | -0.76% | 604,302 | 151.40M |
| 468 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 469 | NPCE | NeuroPace, Inc. | 497.09M | -5.69% | 135,410 | 99.53M |
| 470 | TLRY | Tilray Brands, Inc. | 496.22M | -1.89% | 2,819,998 | 858.28M |
| 471 | KIDS | OrthoPediatrics Corp. | 494.69M | -1.18% | 111,270 | 243.30M |
| 472 | AQST | Aquestive Therapeutics, Inc. | 494.34M | -2.48% | 1,707,555 | 50.27M |
| 473 | WEAV | Weave Communications, Inc. | 488.53M | -9.71% | 1,411,648 | 248.72M |
| 474 | ARTV | Artiva Biotherapeutics, Inc. | 486.85M | 0.20% | 430,403 | 251.00K |
| 475 | NRC | NRC Health | 486.57M | 0.51% | 62,975 | 138.64M |
| 476 | HELP | Cybin Inc. | 484.72M | -3.46% | 2,049,244 | - |
| 477 | VALN | Valneva SE | 463.62M | -0.61% | 10,115 | 180.25M |
| 478 | PROK | ProKidney Corp. | 462.15M | -4.08% | 472,603 | 889.00K |
| 479 | VMD | Viemed Healthcare, Inc. | 456.97M | - | 261,628 | 286.57M |
| 480 | CLPT | ClearPoint Neuro, Inc. | 450.74M | -2.47% | 272,490 | 40.61M |
| 481 | KYTX | Kyverna Therapeutics, Inc. | 449.88M | -1.07% | 542,033 | - |
| 482 | VREX | Varex Imaging Corporation | 449.28M | -0.56% | 272,806 | 857.50M |
| 483 | CABA | Cabaletta Bio, Inc. | 448.40M | -2.48% | 1,836,634 | - |
| 484 | OFIX | Orthofix Medical Inc. | 445.45M | -5.25% | 197,782 | 825.37M |
| 485 | OVID | Ovid Therapeutics Inc. | 444.20M | -1.24% | 1,086,776 | 7.12M |
| 486 | PRTA | Prothena Corporation plc | 441.86M | -3.54% | 542,547 | 57.94M |
| 487 | SRTA | Strata Critical Medical, Inc. | 439.55M | -1.55% | 616,202 | 228.58M |
| 488 | OCGN | Ocugen, Inc. | 436.69M | -0.77% | 3,292,144 | 4.47M |
| 489 | CYH | Community Health Systems, Inc. | 436.16M | 0.31% | 1,347,402 | 11.98B |
| 490 | SGMT | Sagimet Biosciences Inc. | 435.35M | -0.28% | 780,502 | - |
| 491 | DCTH | Delcath Systems, Inc. | 432.56M | -2.19% | 278,082 | 90.44M |
| 492 | PACB | Pacific Biosciences of California, Inc. | 428.63M | -1.43% | 7,737,617 | 160.03M |
| 493 | EDIT | Editas Medicine, Inc. | 426.62M | -3.81% | 1,038,301 | 38.69M |
| 494 | CTEV | Claritev Corporation | 425.85M | -12.93% | 128,651 | 978.76M |
| 495 | EPRX | Eupraxia Pharmaceuticals Inc. | 422.07M | 0.63% | 901,693 | - |
| 496 | SI | Shoulder Innovations, Inc. | 421.19M | -2.36% | 77,349 | 53.89M |
| 497 | LRMR | Larimar Therapeutics, Inc. | 419.62M | 2.29% | 1,311,399 | - |
| 498 | NNNN | Anbio Biotechnology | 414.77M | -0.74% | 34,130 | 8.65M |
| 499 | CCCC | C4 Therapeutics, Inc. | 413.52M | -2.35% | 2,192,491 | 34.86M |
| 500 | EVMN | Evommune, Inc. | 410.61M | -6.71% | 479,120 | 10.00M |